Collaborative Drug Therapy Agreement Review Form

Providers in other health disciplines are looking for ways to reduce the effects of this anticipated shortage of doctors. The increase in primary care and specialized medical stays and the use of nurses and medical assistants (PA) are two current trends in the fight against the shortage of physicians.4,5 This solution becomes complex because the legal scope of the practice is regulated by each state and these rules may not correspond to the professional skills of NPs and APs6. The average American lives five miles from the nearest community pharmacy, making pharmacists and the care they provide highly accessible.7 A collaborative approach is needed to improve patient access to care. National Pharmacy Boards and Commissions regulate pharmacy practice at the state level, resulting in national fluctuations in the use of collaborative drug therapy (CDTA) contracts, also known as collaborative practice agreements (CPAs). While many countries have CDTAs or CPAs, there are big differences in how they can be used. Some states limit the conditions that pharmacists can treat, the drugs they can prescribe and the training they must have.8 In Washington, the Pharmacy Practice Act has allowed all pharmacists to prescribe CDTA drugs since 1979.9 There are no restrictions on the population or conditions of illness they are allowed to treat in the agreements. In recent years, pharmaceutical practices in many countries have been adapted to the evolving role of pharmacists as members of integrated health teams. In California, Montana, New Mexico and North Carolina, an advanced practice pharmacy is assigned to qualified pharmacists, They have the right to prescribe, monitor, manage and distribute drugs.10 While expanding patient access to care is a complex and difficult problem, pharmacists are in an integrated position to provide extensive care to patients who have not received treatment.11 In 2012 , the Food and Drug Administration (FDA) has considered creating a class of pharmacists opposite the store or class of pharmacies opposed to drugs.11 Patients who are not being treated offer more advanced treatment. The creation of a class of drug pharmacists would take into account the need for treatment in three ways: improved access to the care of patients and minor diseases, reducing costs for patients and the health care system and reducing the burden on physicians so that they can focus on critically ill or medically complex patients.13-15 Opposition has highlighted concerns about the quality of care. 15 In response to these concerns, the FDA has decided not to comment on the creation of a class of drug pharmacists. At the end of the online seminar, students had to demonstrate skill by achieving a minimum competency of 80% of 80%, both for an electronic assessment of knowledge and for the practical examination of the patient case. The knowledge assessment included 18 multiple-choice questions and was transmitted electronically via ExamSoft (ExamSoft Worldwide, Inc., Dallas, TX). Questions classified in Bloom`s taxonomy as a level of knowledge or application required students to be informed of complaints and minor conditions or to properly apply this knowledge to patients` short vignettes19 Evaluation questions were designed to have the same degree of difficulty as the scoring quiz and to be associated with clinical module learning objectives.